Japanese venture capital firm University of Tokyo Edge Capital Partners (UTEC) has closed its sixth fund with 47 billion yen (around US$320 million) in committed capital.

This brings the firm’s total assets under management to over US$1 billion.

UTEC plans to invest between US$10 million and US$20 million in seed and early-stage startups in healthcare, life sciences, information technology, and engineering.

Founded in 2004, the firm focuses on science and technology innovations sourced from universities and research institutions.

Its portfolio includes over 150 companies, such as PeptiDream, a peptide-based drug company listed on the Tokyo Stock Exchange, and OriCiro Genomics, which was acquired by Moderna in 2023 for US$85 million.

The firm’s investment strategy is to identify promising technologies through academic research analysis.

UTEC also offers support to startups in areas such as recruitment and global expansion.

Additionally, the firm invests internationally, targeting startups in the United States, India, Southeast Asia, and Europe while assisting Japanese startups in expanding abroad.

The launch of this fund aligns with Japan’s broader efforts to enhance its startup ecosystem, as the Japanese government aims to increase startup investments to 10 trillion yen (around US$68 billion) by 2027.

🔗 Source: Forbes

🧠 Food for thought

1️⃣ Japan’s transformation from innovation laggard to deep tech catalyst

Japan’s startup investment has surged tenfold from 877 billion yen in 2013 to over 8,774 billion yen in 2022, reflecting a dramatic shift in the country’s innovation landscape 1.

This growth follows a period when Japan struggled significantly with entrepreneurship. In 2016, Japan ranked last among 24 developed nations in entrepreneurial activity, with venture capital investment at only $629 million compared to $59 billion in the U.S. that year 2.

UTEC’s new fund represents a key piece of Japan’s national startup development plan announced in 2022, which aims to increase startup investment to 10 trillion yen by 2027 and create 100 unicorns, marking a significant departure from the country’s historical risk aversion.

The focus on deep tech specifically addresses Japan’s strengths in scientific research while tackling its traditional weakness in commercializing innovations. This creates a strategic pathway to global competitiveness, leveraging the country’s academic excellence.